United Nations Office for Drugs and Crime (UNODC). World Drug Report. Vienna: United Nations Publication; 2015.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2015: trends and development. Lisbon: European Union; 2015.

National Institute of Health and Clinical Excellence (NICE). CG 51 Drug misuse: psychosocial interventions. London: National Institute of Clinical Excellence; 2007.

 National Institute on Drug Abuse (NIDA). Principles of drug addiction treatment: a research base-guide. 3rd ed. Bethesda: National Institutes of Health, U.S. Department of Health and Human Services; 2014.

 Department of Health (DHD). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government, and Northern Ireland Executive; 2007.

Fischer B, Blanken P, Da Silveira D, Gallassi A, Goldner EM, Rehm J, et al. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies. Int J Drug Policy. 2015;26:352-63.

Kiluk BD, Carroll KM. New developments in behavioral treatments for substance use disorders. Curr Psychiatry Rep. 2013;15:420. 

Carroll KM, Kiluk MD, Nich C, Gordon MA, Portnoy GA, Marino DR, et al. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of cbt4cbt among cocaine-dependent individuals maintained on methadone. Am J Psychiatry. 2014;171:436-44. 

Petitjean SA, Dürsteler-MacFarland KM, Krokar MC, Strasser J, Mueller SE, Degen B, et al. A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence. Drug Alcohol Depend. 2014;145:94-100.

Shearer J, Tie H, Byford S. Economic evaluations of contingency management in illicit drug misuse programmes: a systematic review. Drug Alcohol Rev. 2015;34:289-98. 

 Blodgett JC, Maisel NC, Fuh IL, Wilbourne PL, Finney JW. How effective is continuing care for substance use disorders? A meta-analytic review. J Subst Abuse Treat. 2014;46:87-97.

Grant S, Hempel S, Colaiaco B, Motala A, Shanman RM, Booth M, et al. Mindfulness-based relapse prevention for substance use disorders: a systematic review. Santa Monica: National Defense Research Institute, RAND Corporation; 2015.

Shorter D, Domingo CB, Kosten TR. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opin Emerg Drugs. 2015;20:15-29.